載入...
Comparison of health technology assessment for new medicines in France and England: an example based on ixazomib for patients with relapsed or refractory multiple myeloma
Introduction: The appraisal of medicines is often a complex and iterative process. We compared the health technology assessment (HTA) process in England and France taking as a case study the example of ixazomib for multiple myeloma. Methods: We undertook an analysis of eight relevant published docum...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Taylor & Francis Group
2019-01-01
|
| 叢編: | Journal of Market Access & Health Policy |
| 主題: | |
| 在線閱讀: | http://dx.doi.org/10.1080/20016689.2019.1648971 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|